PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC
James Chih‐Hsin Yang(National Taiwan University)
Cited by 1
Related Papers
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma
|JAMA Oncology|2017|632
Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer
|Journal of Thoracic Oncology|2019|83
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
|PLoS ONE|2015|48
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
|Anticancer Research|2021|28